These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 24448555)

  • 21. Lysosome-targeted chemotherapeutics: Anticancer mechanism of N-heterocyclic carbene iridium(III) complex.
    Zhang J; Liu J; Liu X; Liu B; Song S; He X; Che C; Si M; Yang G; Liu Z
    J Inorg Biochem; 2020 Jun; 207():111063. PubMed ID: 32222581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Half-sandwich iridium(III) complexes with α-picolinic acid frameworks and antitumor applications.
    Hao H; Liu X; Ge X; Zhao Y; Tian X; Ren T; Wang Y; Zhao C; Liu Z
    J Inorg Biochem; 2019 Mar; 192():52-61. PubMed ID: 30597449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structurally Strained Half-Sandwich Iridium(III) Complexes As Highly Potent Anticancer Agents.
    Carrasco AC; Rodríguez-Fanjul V; Habtemariam A; Pizarro AM
    J Med Chem; 2020 Apr; 63(8):4005-4021. PubMed ID: 32207946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
    Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DFT Investigation of the Mechanism of Action of Organoiridium(III) Complexes As Anticancer Agents.
    Ritacco I; Russo N; Sicilia E
    Inorg Chem; 2015 Nov; 54(22):10801-10. PubMed ID: 26492153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Half-sandwich Iridium(III) Benzimidazole-Appended Imidazolium-Based N-heterocyclic Carbene Complexes and Antitumor Application.
    Han Y; Liu X; Tian Z; Ge X; Li J; Gao M; Li Y; Liu Y; Liu Z
    Chem Asian J; 2018 Dec; 13(23):3697-3705. PubMed ID: 30276978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, structure, and antiproliferative activity of ruthenium(II) arene complexes with N,O-chelating pyrazolone-based β-ketoamine ligands.
    Pettinari R; Marchetti F; Pettinari C; Petrini A; Scopelliti R; Clavel CM; Dyson PJ
    Inorg Chem; 2014 Dec; 53(24):13105-11. PubMed ID: 25412203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia-Sensitive Metal β-Ketoiminato Complexes Showing Induced Single-Strand DNA Breaks and Cancer Cell Death by Apoptosis.
    Lord RM; Hebden AJ; Pask CM; Henderson IR; Allison SJ; Shepherd SL; Phillips RM; McGowan PC
    J Med Chem; 2015 Jun; 58(12):4940-53. PubMed ID: 25906293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel bis-C,N-cyclometalated iridium(III) thiosemicarbazide antitumor complexes: interactions with human serum albumin and DNA, and inhibition of cathepsin B.
    Ruiz J; Vicente C; de Haro C; Bautista D
    Inorg Chem; 2013 Jan; 52(2):974-82. PubMed ID: 23301676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands.
    Yang Y; Guo L; Ge X; Shi S; Gong Y; Xu Z; Zheng X; Liu Z
    J Inorg Biochem; 2019 Feb; 191():1-7. PubMed ID: 30445339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (Pentamethylcyclopentadienyl)chloridoiridium(III) Complex Bearing Bidentate Ph
    Ludwig G; Ranđelović I; Dimić D; Komazec T; Maksimović-Ivanić D; Mijatović S; Rüffer T; Kaluđerović GN
    Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
    Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
    Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Wang FX; Chen MH; Hu XY; Ye RR; Tan CP; Ji LN; Mao ZW
    Sci Rep; 2016 Dec; 6():38954. PubMed ID: 27958338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contrasting Anticancer Activity of Half-Sandwich Iridium(III) Complexes Bearing Functionally Diverse 2-Phenylpyridine Ligands.
    Millett AJ; Habtemariam A; Romero-Canelón I; Clarkson GJ; Sadler PJ
    Organometallics; 2015 Jun; 34(11):2683-2694. PubMed ID: 26146437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mitochondria-targeting hetero-binuclear Ir(iii)-Pt(ii) complex induces necrosis in cisplatin-resistant tumor cells.
    Ouyang C; Chen L; Rees TW; Chen Y; Liu J; Ji L; Long J; Chao H
    Chem Commun (Camb); 2018 Jun; 54(49):6268-6271. PubMed ID: 29850704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
    Lee PK; Law WH; Liu HW; Lo KK
    Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vitro antitumor activity of novel iridium(III) complexes with enantiopure C2-symmetrical vicinal diamine ligands.
    Yang Q; Chang J; Song J; Qian MT; Yu JM; Sun X
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4602-7. PubMed ID: 23849808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
    Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thiabendazole-based Rh(III) and Ir(III) biscyclometallated complexes with mitochondria-targeted anticancer activity and metal-sensitive photodynamic activity.
    Pérez-Arnaiz C; Acuña MI; Busto N; Echevarría I; Martínez-Alonso M; Espino G; García B; Domínguez F
    Eur J Med Chem; 2018 Sep; 157():279-293. PubMed ID: 30099251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.